Orphion Therapeutics
About:
Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders.
Website: https://www.orphiontherapeutics.com/
Description:
Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders. It was founded and is led by an executive management team experienced in drug development with the backing of respected healthcare investors.
Total Funding Amount:
$5.33M
Headquarters Location:
Great Neck, New York, United States
Founded Date:
2020-01-01
Founders:
Sam Backenroth
Number of Employees:
1-10
Last Funding Date:
2020-11-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai